028230000a22003730004500 PH-MaWHO 20241108112355.0 United States. Agency for International Development. Technical Guidance / Competence Working Group. 658530 Recommendations for updating selected practices in contraceptive use. Volume II. [Washington, D.C.] : USAID, Technical Guidance / Competence Working Group, 1997. 260p. UTT 1994 - v.2 eng RPH Cervix neoplasms 658531 Contraception 117404 Counseling 119619 Developing countries 130222 Healthplanning 644507 Healthplanning guidelines 658056 Public relations 292557 Quality of health care 296077 Reproductive medicine 423336 Sexually transmitted diseases 314577 Ambulatory care facilities 60623 Behavior 658532 Family planning 643099 Healthservices research 644988 Interpersonal relations 203523 Program evaluation 370034 World Health Organization 658533 Includes bibliographical references. (50 plus ref.). ; This volume presents recommendations developed by the Technical Guidance/Competence Working Group of the US Agency for International Development, in collaboration with the World Health Organization, for updating contraceptive delivery services to make them consistent with current clinical and epidemiologic evidence. Its objective is to improve both access to and the quality of family planning (FP) services through better use of resources. Section 1 contains information in a question-and-answer format on female sterilization, vasectomy, combined injectable contraceptives, levonorgestrel-releasing IUDs, the lactational amenorrhea method, natural FP, withdrawal, progestin-only pills during breast feeding, barrier methods, and oral contraceptives as emergency contraceptive pills. Pelvic examination, blood pressure, breast examination, sexually transmitted disease (STD) screening, cervical cancer (CC) screening, mandatory lab tests, infection prevention procedures, and counseling are discussed in relation to each of these methods. Section 2 contains checklists for use by health care workers in community-based service settings to use to identify appropriate candidates for combined oral contraceptive and injectable use. Finally, Section 3 contains information on reproductive health issues such as client-provider interaction, contraceptive method efficacy, STD risk assessment, dual method use, FP methods, protection against STDs, and CC prevention. MONO 8790 8790 0 0 0 0 WPRO WPRO 2021-05-23 0 UTT 1994 - v.2 08790 2024-01-24 00:00:00 2021-05-23 MONO